Skip to main content
logo
Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.7445
-0.0627 (-7.77%)
At close: May 4, 2026, 4:00 PM EDT
0.7599
+0.0154 (2.07%)
After-hours: May 4, 2026, 7:44 PM EDT

Vivos Therapeutics Revenue

In the year 2025, Vivos Therapeutics had annual revenue of $17.44M with 16.05% growth. Vivos Therapeutics had revenue of $3.82M in the quarter ending December 31, 2025, with 3.41% growth.

Revenue (ttm)
$17.44M
Revenue Growth
+16.05%
P/S Ratio
0.58
Revenue / Employee
$65,086
Employees
268
Market Cap
10.04M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202517.44M2.41M16.05%
Dec 31, 202415.03M1.23M8.91%
Dec 31, 202313.80M-2.22M-13.87%
Dec 31, 202216.02M-861.00K-5.10%
Dec 31, 202116.89M3.82M29.23%
Dec 31, 202013.07M1.67M14.68%
Dec 31, 201911.39M7.60M200.44%
Dec 31, 20183.79M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Trinity Biotech43.79M
Beyond Air6.92M
Biomerica4.33M
Tenon Medical3.94M
Intelligent Bio Solutions3.58M
Sintx Technologies1.02M
Co-Diagnostics622.49K
iTonic Holdings523.03K
Revenue Rankings

VVOS News

More News